Mandolin

Overview

Mandolin is a provider-side AI automation platform for specialty-drug access workflows. Its strongest public fit is the operational gap between a prescription or referral and a cleared specialty therapy: intake, benefits verification, prior authorization documentation, payer follow-up, billing status, and appeals support for infusion centers, specialty pharmacies, and health-system specialty programs.

For manufacturer launch teams, Mandolin is not a classic hub-services vendor. It matters when office-administered or buy-and-bill therapies depend on provider back-office capacity, payer documentation, EHR workflow, and infusion-site throughput. A launch team would evaluate Mandolin to understand whether provider partners can clear patients faster and feed reliable status back into the broader access model.

Reimbursement and PA Capability Model

The framework below standardizes how Rx Almanac evaluates reimbursement-prior-auth capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Mandolin is evaluated as provider-side AI automation platform for specialty-drug access workflows.

Capability	Buyer should compare	Mandolin readout
Electronic PA initiation and payer connectivity	ePA submission, payer integrations, plan-specific requirements, real-time decisioning, and transaction reach.	Specialty / provider-side fit. Strongest for medical-benefit and infusion workflows where PA work spans charts, policy criteria, portals, calls, and provider operations. Validate pharmacy-benefit ePA reach separately.
Benefits verification and coverage discovery	Eligibility, pharmacy/medical benefit checks, policy criteria, coverage route, and reimbursement path identification.	Core. Mandolin is designed around benefits verification and reimbursement-path work for specialty-drug administration, especially when coverage discovery is tied to infusion workflow.
Clinical documentation and appeals support	Document collection, criteria matching, appeal packets, peer-to-peer prep, and denial management.	Core. Public materials emphasize AI agents that parse clinical notes, faxes, and payer policy requirements. Buyers should validate human review, clinical governance, and appeal packet ownership.
Provider workflow integration	EHR, portal, fax, call, pharmacy, and practice-management workflows that reduce office burden.	Core. Mandolin’s differentiation is workflow integration across provider systems, payer portals, fax/call channels, and manufacturer or hub touchpoints rather than a standalone manufacturer case-management layer.
Automation, AI, and queue prioritization	AI agents, rules engines, form completion, status retrieval, queue triage, and exception handling.	Core. The platform uses AI agents for repetitive access and billing work. Diligence should test exception handling, audit logs, model governance, and liability boundaries.
Reporting, status visibility, and policy intelligence	Case status, payer trend reporting, denial reasons, turnaround metrics, and policy-change intelligence.	Confirm reporting layer. Status visibility is valuable to hubs and field reimbursement teams, but buyers should confirm which data can be shared back to manufacturers, through which integrations, and under what consent model.

Buyer Fit

• Best buying context: Office-administered specialty therapies, infusion-heavy launches, and buy-and-bill products where provider administrative burden is a material access constraint.
• Most relevant buyers: Market access, patient services, field reimbursement, channel strategy, and trade teams that need provider-side workflow visibility without replacing the hub or specialty-pharmacy partner.
• Strongest operating context: Infusion centers, health-system specialty pharmacies, and provider organizations handling high-cost therapies with complex documentation, benefit checks, medical policies, claims follow-up, and reauthorization cycles.
• Less natural fit: Simple retail-pharmacy ePA, broad CRM/case-management replacement, payer-side utilization management, or manufacturer programs that only need a hub vendor to manage patient services.
• Staffing diligence: Confirm live EHRs and payer portals, medical-benefit versus pharmacy-benefit depth, manufacturer data-sharing permissions, human-in-the-loop controls, implementation timeline, and exception ownership.

Differentiators

• Provider-side specialty focus: Mandolin is organized around the access work inside infusion and specialty-drug provider operations rather than generic PA software.
• AI-agent operating model: The product targets intake, benefits verification, PA documentation, portal work, billing follow-up, and appeals as coordinated tasks instead of isolated form automation.
• Unstructured-document handling: The platform’s value increases where faxes, handwritten notes, chart extracts, policy criteria, and payer responses still drive the workflow.
• Channel-adjacent manufacturer relevance: For buy-and-bill launches, Mandolin can affect patient start speed through provider partners even when the manufacturer is not the direct software buyer.

RFP Questions

• Which EHRs, payer portals, fax/call workflows, and manufacturer-hub touchpoints are live for the therapy’s expected provider network?
• How does Mandolin distinguish medical-benefit, pharmacy-benefit, and mixed-benefit workflows?
• What actions can the AI complete without human review, and which require provider staff approval?
• How are clinical-policy interpretation, documentation matching, denial management, appeals, and reauthorizations audited?
• What status data can flow back to hubs, specialty pharmacies, field reimbursement teams, and manufacturers?
• What implementation work is required from provider IT, revenue cycle, pharmacy operations, and compliance teams?

Recent Activity

• 2026: Public recognition for Mandolin’s founders reinforced the company’s visibility in AI-enabled healthcare operations.
• 2025: Public materials described Mandolin as operating across hundreds of clinic locations and serving specialty-drug workflows for infusion and pharmacy providers.
• 2025: Mandolin publicly announced an AI-agent platform for specialty-drug access, including prior authorization, benefits verification, billing, EHR workflows, and manufacturer-hub coordination.
• 2024: Mandolin was founded in San Francisco.